What it does:

Disrupts abnormal cell structures through microtubule destabilization, blocks glucose uptake, inhibits glutamine pathways, and induces apoptosis (programmed cell death) in dysfunctional cells.

The science:

Benzimidazoles like Fenbendazole have demonstrated effects through microtubule polymerization inhibition, cell cycle arrest (G2/M), and anti-angiogenesis. Apoptosis is induced through mitochondrial injury mediated by p53 expression (Mukhopadhyay et al., 2002; Park et al., 2022). Research shows Fenbendazole targets dysfunctional stem cells and chemoresistant cells (Son et al., 2020).

Case evidence:

Three patients with stage IV genitourinary malignancies treated at 1,000mg three times weekly experienced complete remission (Chiang et al., 2021). Two had experienced progression despite multiple prior treatments.

What it does:

Induces autophagy and apoptosis in abnormal cells through mitochondrial mediation. Regulates pyruvate kinase at the last step of glycolysis. Has a selective pro-oxidant effect on dysfunctional cells while sparing healthy ones.

The science:

Ivermectin induces apoptosis through mitochondrial dysfunction (Juarez et al., 2018; Tang et al., 2021). In vitro, it's more effective at inhibiting dysfunctional stem cells than standard chemotherapy drugs like paclitaxel (Dominguez-Gomez et al., 2018). In vivo, Ivermectin alone outperformed gemcitabine at reducing tumor weight and volume in pancreatic models (Lee et al., 2022).

Safety profile:

Single doses up to 2mg/kg showed no serious adverse reactions in healthy volunteers (Guzzo et al., 2002). Patients taking up to 1mg/kg daily for 180 consecutive days experienced no serious adverse effects (de Castro et al., 2020).

What it does:

At high doses, Vitamin C acts as a pro-oxidant in abnormal cells (not an antioxidant), generating hydrogen peroxide that selectively kills dysfunctional cells while protecting healthy ones. Competes directly with glucose for cellular entry via GLUT1 receptors.

The science:

High-dose Vitamin C kills abnormal cells through a pro-oxidant mechanism but not normal cells (Chen et al., 2005, 2008). It inhibits both glycolysis (Aguilera et al., 2016) and the pentose phosphate pathway in abnormal cells, while sparing healthy cells that have catalase to neutralize H2O2.

Why liposomal:

Achieves plasma concentrations approaching IV administration without clinic visits. Standard oral Vitamin C is poorly absorbed; liposomal delivery dramatically increases bioavailability.

What it does:

Targets mitochondria by improving metabolism and regulating respiration. Inhibits both glycolysis and glutaminolysis pathways. Targets dysfunctional stem cells and metastasis.

The science:

Meta-analyses show inverse correlations between serum Vitamin D levels and incidence for at least 12 different types of abnormal growths (Muñoz & Grant, 2022). Chandler et al. demonstrated a 37% reduction in metastatic incidence and 42% reduction in mortality with supplementation in a published clinical study. VDR activation suppresses Wnt/β-catenin signaling in dysfunctional stem cells.

What it does:

Protects mitochondria from reactive oxygen species damage. Induces mitochondrial pyruvate transport, oxidative phosphorylation, and ATP production. Blocks energy production in abnormal cells and inhibits glycolysis.

The science:

There are 151 publications confirming the link between zinc deficiency and malignancy (Sugimoto et al., 2024). Zinc deficiency is implicated in esophageal, liver, lung, breast, and colon abnormalities. Zinc has a selective pro-oxidant effect on dysfunctional cells and has been studied for blocking their energy production. Copper is included to maintain essential mineral balance.

What it does:

Potent anti-inflammatory that synergizes with Fenbendazole. Inhibits NF-κB pathway (master regulator of inflammation), induces apoptosis, and has demonstrated effects on abnormal stem cells.

The science:

Curcumin enhances the effects of conventional treatments while reducing their side effects. Multiple studies show it targets dysfunctional stem cells through Wnt/β-catenin, Notch, and Hedgehog pathways. The inflammation-abnormal growth connection is direct: NF-κB is constitutively active in most abnormal cells. Piperine increases curcumin bioavailability by 2,000%.

What it does:

Reduces inflammation, enhances apoptosis in abnormal cells, and provides neuroprotective effects. Also helps with pain management, sleep quality, and anxiety — critical quality-of-life factors.

The science:

CBD induces apoptosis through multiple mechanisms including ceramide accumulation and ER stress. It enhances the effects of conventional treatments in preclinical models. Beyond direct cellular effects, CBD's support for sleep and stress reduction has measurable immune benefits — immune surveillance peaks during quality sleep.

What it does:

Binds iron, depriving abnormal cells of a key nutrient. Modulates immune function. Synergizes with Ivermectin for enhanced effects.

The science:

Abnormal cells require significantly more iron than healthy cells. Lactoferrin's iron-chelating properties selectively starve these cells. It also activates NK cells and macrophages while inhibiting abnormal cell proliferation through cell cycle arrest. Research shows synergistic effects with Ivermectin in targeting dysfunctional stem cells.

What it does:

Contains thymoquinone, which induces apoptosis, inhibits proliferation, and supports detoxification pathways. Powerful antioxidant for healthy cell protection.

The science:

Thymoquinone has demonstrated effects against abnormal cells through ROS generation, cell cycle arrest, and apoptosis induction. It protects healthy cells from oxidative damage during treatment protocols. Traditional use for over 2,000 years with modern research validating its mechanisms across multiple published studies.

What it does:

Contains EGCG which inhibits glutamine pathways and boosts oxidative phosphorylation (OxPhos) — the healthy energy production pathway that abnormal cells cannot use effectively.

The science:

EGCG inhibits glutamine uptake and metabolism in abnormal cells. It also enhances mitochondrial function in healthy cells, creating a metabolic advantage. Multiple epidemiological studies link green tea consumption to reduced incidence of various abnormal growths. EGCG synergizes with Fenbendazole and Ivermectin's metabolic targeting.

What it does:

Protects liver function during intensive protocols. Contains silymarin which has direct effects on abnormal cells while supporting detoxification.

The science:

Silymarin protects hepatocytes from toxicity while independently inhibiting abnormal cell growth through multiple mechanisms. Essential for high-dose regimens involving Fenbendazole and Ivermectin, which are metabolized by the liver. Also supports glutathione production — the body's master antioxidant.

What it does:

Blocks galectin-3, a protein that abnormal cells use for adhesion, aggregation, and spread. Supports detoxification of heavy metals.

The science:

Galectin-3 is overexpressed in abnormal cells and facilitates metastatic spread. Modified citrus pectin binds galectin-3, inhibiting cell-to-cell adhesion and blocking a key metastatic pathway. Clinical studies show reductions in PSA doubling time and other markers. Also chelates heavy metals without depleting essential minerals.

What it does:

Contains PSK and PSP polysaccharides that enhance immune function, particularly NK cell and T-cell activity. Used for decades in Japan as an adjunct to conventional treatments.

The science:

PSK (Krestin) is an approved adjunct therapy in Japan with extensive clinical research. Meta-analyses show improved survival rates when added to standard treatments. Enhances both innate and adaptive immunity, helping the body recognize and target abnormal cells. Over 40 clinical trials published.